NSPR InspireMD Inc

$NSPR Similar to the run up before Q2 earnings when we expected fda approval, i'm expecting something similar very soon. New job openings show that approval is imminent for both CGuard Prime AND TCAR designation.

$NSPR three territory manager positions opened up today via LinkedIn. Approvals seem imminent.

$NSPR Maybe a good time to start drinking the Kool Aid...or at least give it a very good thought. We either dance in the streets in 2027 or we die. Knowing a bit about the effort going into getting this to a new reallity...Ive started sipping.

$NSPR Anyone else wonder what they do all day at InspireMD? I mean you have a payroll that is enormous sitting around accomplishing nothing. Literally nothing. No product - just waiting on the FDA to ask them another question that should have already been answered. The FDA is not some mystical organization. MOST ..like MOST questions they ask are questions you should have already answered. The incompetence is mind boggling.

$NSPR Day 7 of Q4 and 2 months after the expected August 2026 approval of the legacy system... Still nothing.

$NSPR This is one prediction I'd hope to have missed. If I am going to invest more, it will be after the news of FDA approval of original delivery system or new (and any re-commercialization news and any forthcoming RS+Dilution crap. Saying nothing = doing nothing in the market's estimation, and for NSPR, at present, that means the one trick pony is stuck in the stable.

$NSPR Starting to concern me how long it is taking to get FDA clearance on the legacy delivery system. There has to be something they are not telling us. It was used in the trials and in over 70,000 procedures world wide....and we are past the 'typical' timeframe for approval.

$NSPR what a steal at this price. Bought more again today; it will be nice on the TCAR bounce buying here.

$NSPR I think if the company issues more warrants this stock has a shot at a comeback. The lower the better.

$NSPR don’t worry, loyal shark says the next RS will really be the one to draw institutional investors 😂 🤡

$NSPR FDA approval will no longer save this company. They have basically zero cash runway for any launch and still lose money even they are selling. Why would anyone invest the millions it will take to successfully launch and turn profitable with this kind of incompetent organisation, why you would anyone buy this company to infect themselves with these people. still say bankruptcy and a sell off of the IP.

$NSPR new October presentation is out. Nothing new from the previous presentation that I can remember. It would be nice to see them move up SwitchGuard to 1H 2027 so you have 4 catalyst back to back over the next 8 months but beggars can’t be choosers

$NSPR I can't think of a single reason why anyone would invest in this company even with FDA approval. The company literally has no money to launch and get this thing to scale and profitable. Cheaper to just buy out the company and integrate the IP, yet at 22 million MC, nobody is buying. Something ain't right.

$NSPR calling anyone but a lawyer won't make any difference....this canoe is sinking and only con man Marvin has a lifejacket...the end is near

$NSPR And, there it is. Under $.50 per share for a best in class tech device. All due to mismanagement of the creation and launch of the new delivery system for the US Market. Congratulations NSPR Leadership on being most un-inspiring with your ineffective address and resolution of this key issue, to date. Keep this up and absent of or inclusive of a reverse split, the stock will be between $.30-35 per share (or the reverse split equivalent) with tax loss selling by Dec 31.

$NSPR don’t look at me, I’ve been warning against this cat turd for years. Some cheerleaders even poked at me for my number of followers and such. 😂😂 rah rah sis boom bah. This old, wise guy at the end of the bar doesn’t need to win a Stocktwits popularity contest 😂😂🍻

$NSPR astonishing. For something with so many positives they really managed to shit the bed 😂

$NSPR a lot of shares getting traded in the first hour today. Someone’s accumulating for a pop

$NSPR if I were a medical professional, considering adopting this technology for my hospital or my practice, I would reject it simply on the basis of the stock price and the obvious management incompetence.

$NSPR This guy is too cheap or stupid to invest a dime in IR With such a great story to tell…